Topic: How can clinicians minimize heart problems in their patients with breast cancer? Radiation therapy and anthracycline-based chemotherapy have value in breast cancer, but the benefit can exact a steep price. Join us on Twitter to discuss how experts identify cardiotoxicity risk factors and use specific management techniques to protect the heart.
Expert Participants: , Co-Director, Cardiac Radiology Services, MD Anderson Cancer Center (); and , Director, Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center ()
When: Wednesday, Dec. 12, 11:00 a.m. - 12:00 p.m. ET.
How to Join: Make sure to follow us on Twitter and join the discussion live on our feed. Use the hashtag #CardioOncoConnect when you tweet; we encourage you to comment, answer questions, ask questions, and react during the chat.
Click to be taken directly to the chat.
Previous Related Cardio-Oncology Connection Articles and Videos:
Management of Cancer Therapy-Induced Left-Ventricular Dysfunction: Can the Guidelines Help?
Trastuzumab Tied to Heart Issues in Breast Ca Patients
Studies: Long-Term Heart Risks After Breast Cancer Tx
Minimizing Heart Failure Risk after Breast Cancer RT
Pinpointing CV Risk Factors in Breast Cancer Patients
Anti-HER2 Therapies: Monitoring for Decreases in Heart Function